Novartis India Ltd Q3 FY2024 profit higher at Rs. 26.57 crores

Novartis India Limited has reported Standalone financial results for the period ended December 31, 2023.

Financial Results (Q3 FY2024) - QoQ Comparison

The company has reported total income of Rs. 106.50 crores during the period ended December 31, 2023 as compared to Rs. 95.64 crores during the period ended September 30, 2023.

The company has posted net profit / (loss) of Rs. 26.57 crores for the period ended December 31, 2023 as against net profit / (loss) of Rs. 23.68 crores for the period ended September 30, 2023.

The company has reported EPS of Rs. 10.76 for the period ended December 31, 2023 as compared to Rs. 9.59 for the period ended September 30, 2023.

Financials	Q3 FY2024	Q2 FY2024	% Change
Total Income	₹ 106.50 crs	₹95.64 crs	11.36%
Net Profit	₹26.57 crs	₹23.68 crs	12.20%
EPS	₹10.76	₹9.59	12.20%

Financial Results (Q3 FY2024) - YoY Comparison

The company has reported total income of Rs. 106.50 crores during the period ended December 31, 2023 as compared to Rs.88.53 crores during the period ended December 31, 2022.

The company has posted net profit / (loss) of Rs.26.57 crores for the period ended December 31, 2023 as against net profit / (loss) of Rs.7.61 crores for the period ended December 31, 2022.

The company has reported EPS of Rs.10.76 for the period ended December 31, 2023 as compared to Rs.3.08 for the period ended December 31, 2022.

Financials	Q3 FY2024	Q3 FY2023	% Change
Total Income	₹ 106.50 crs	₹88.53 crs	20.30%
Net Profit	₹26.57 crs	₹7.61 crs	249.15%
EPS	₹10.76	₹3.08	249.35%

Financial Results (9 Months Ended FY2024) - YoY Comparison

The company has reported total income of Rs.305.16 crores during the 9 Months period ended December 31, 2023 as compared to Rs.344.35 crores during the 9 Months period ended December 31, 2022.

The company has posted net profit / (loss) of Rs.70.51 crores for the 9 Months period ended December 31, 2023 as against net profit / (loss) of Rs.78.34 crores for the 9 Months period ended December 31, 2022.

The company has reported EPS of Rs.28.56 for the 9 Months period ended December 31, 2023 as compared to Rs.31.74 for the 9 Months period ended December 31, 2022.

Financials	9 Months Ended FY2024	9 Months Ended FY2023	% Change
Total Income	₹305.16 crs	₹344.35 crs	-11.38%
Net Profit	₹70.51 crs	₹78.34 crs	-9.99%
EPS	₹28.56	₹31.74	-10.02%

Shares of Novartis India Limited was last trading in BSE at Rs. 914.30 as compared to the previous close of Rs. 882.55. The total number of shares traded during the day was 28077 in over 1010 trades.

The stock hit an intraday high of Rs. 921.80 and intraday low of 883.05. The net turnover during the day was Rs. 25523639.00.

Source : Equity Bulls

Keywords

NovartisIndia Q3FY24 9MFY24 ResultUpdate